The official Shiba Inu account on X lost its gold verification checkmark this week, sparking widespread concern among the token's 3.9 million followers. The unexpectedThe official Shiba Inu account on X lost its gold verification checkmark this week, sparking widespread concern among the token's 3.9 million followers. The unexpected

Why Did Shiba Inu Suddenly Remove Its Gold Check?

2025/12/21 16:38
2 min read
For feedback or concerns regarding this content, please contact us at crypto.news@mexc.com

The official Shiba Inu account on X lost its gold verification checkmark this week, sparking widespread concern among the token's 3.9 million followers. The unexpected change triggered speculation across the cryptocurrency community about potential problems within the project.

The move affected multiple accounts connected to the Shiba Inu ecosystem. K9 Finance, a Shibarium participant, confirmed that affiliate verification badges linked to the main account's business subscription were removed. The change impacted several key projects including Shib Metaverse, ShibariumNet, and developer Kaal Dhairya's account.

Strategic Decision Behind Badge Removal

LC, the administrator of the Shiba Inu X account, clarified the situation directly with affected partners. The decision came down to cost reduction rather than any shift in project direction or relationships. K9 Finance shared this information after speaking with account management.

The official account addressed the situation publicly, confirming several operational changes. The team reapplied the gold verification badge but eliminated affiliate connections. Management emphasized that priorities remain unchanged, with attention focused squarely on the SHIB token itself.

The adjustment follows recent criticism from community members regarding the account's content strategy. Some followers expressed dissatisfaction with posts promoting tokens outside the Shiba Inu ecosystem. The streamlined approach appears to address these concerns while reducing operational expenses.

Business subscriptions on X come with monthly fees that scale based on affiliated accounts. By removing these connections, the project cuts recurring costs without affecting core operations. Each affiliated badge requires separate verification and ongoing subscription payments.

Market Performance Remains Steady

SHIB traded at $0.000007383 at press time, showing a 1.44% decline over 24 hours. The token reversed a five-day losing streak with a sharp rally to $0.00000765 on Friday. Price action suggests investors viewed the verification changes as administrative rather than substantive.

SHIB price chart, Source: CoinMarketCap

Coinbase launched Shiba Inu perpetual futures this week, expanding trading options for the memecoin. The new product offers leveraged exposure to SHIB price movements. This development provides additional liquidity and institutional access to the token.

Market Opportunity
Checkmate Logo
Checkmate Price(CHECK)
$0.049928
$0.049928$0.049928
+0.48%
USD
Checkmate (CHECK) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact crypto.news@mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Vitalik Buterin to Ethereum Developers: Build It Like It Has to Last Without You

Vitalik Buterin to Ethereum Developers: Build It Like It Has to Last Without You

Key Takeaways Vitalik Buterin wants Ethereum apps built to survive without developers, corporate servers, or trusted third parties Two major […] The post Vitalik
Share
Coindoo2026/03/07 15:49
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26
Short-term profit-taking pushes Bitcoin back below key $70K level – What next?

Short-term profit-taking pushes Bitcoin back below key $70K level – What next?

The post Short-term profit-taking pushes Bitcoin back below key $70K level – What next? appeared on BitcoinEthereumNews.com. Bitcoin [BTC] rallied as high as $74
Share
BitcoinEthereumNews2026/03/07 16:09